Re:Biohackers take aim at big pharma’s stranglehold on insulin
by secabeen on Monday June 28, 2021 @06:03PM
(#27668813)
One big element is that a lot of large companies and non-profits run their insurance programs as self-insured. They pay the direct costs of the medical care of their insureds, and keep the annual premiums the entire employee-base pays. The "insurance companies" are paid a percentage of the total revenue/claims as an administration fee, so they have incentives to push the overall amounts paid up, not down. Self-insuring eliminates the profit overhead of the insurance companies, but screws the incentives.
[ Parent
| on HN ]
Re:Biohackers take aim at big pharma’s stranglehold on insulin
by lotsofpulp on Monday June 28, 2021 @06:39PM
(#27669214)
There are quite a few big insurers (better known as managed care organizations) competing for business, so the incentives are there to limit expenses so they don’t have the most expensive premiums.